| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
33,370 |
28,161 |
$2.28M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
15,071 |
13,446 |
$1.58M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,286 |
5,175 |
$459K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
9,174 |
8,200 |
$457K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,763 |
4,317 |
$453K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,263 |
4,190 |
$374K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
10,423 |
9,333 |
$269K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,854 |
2,804 |
$255K |
| S9451 |
Exercise classes, non-physician provider, per session |
17,911 |
16,193 |
$250K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
7,349 |
6,774 |
$228K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
9,076 |
8,743 |
$213K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,699 |
2,529 |
$137K |
| 90461 |
|
4,841 |
4,695 |
$134K |
| 99381 |
|
758 |
687 |
$64K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,250 |
2,068 |
$61K |
| 90723 |
|
1,375 |
1,344 |
$55K |
| 97803 |
|
15,185 |
14,305 |
$53K |
| 90686 |
|
1,636 |
1,597 |
$41K |
| 87807 |
|
2,154 |
1,924 |
$38K |
| 83655 |
|
670 |
652 |
$29K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
843 |
805 |
$26K |
| 99177 |
|
1,294 |
1,147 |
$24K |
| 90647 |
|
1,369 |
1,325 |
$23K |
| 81003 |
|
1,160 |
1,068 |
$21K |
| 90707 |
|
1,395 |
1,356 |
$18K |
| 93000 |
|
531 |
519 |
$17K |
| 90633 |
|
1,388 |
1,340 |
$16K |
| 90700 |
|
427 |
403 |
$16K |
| 99383 |
|
129 |
127 |
$14K |
| 90671 |
|
351 |
348 |
$13K |
| 90670 |
|
1,978 |
1,912 |
$13K |
| 90680 |
|
1,120 |
1,077 |
$12K |
| 90696 |
|
444 |
440 |
$12K |
| 90651 |
|
824 |
802 |
$10K |
| 99050 |
|
1,652 |
1,526 |
$9K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
805 |
734 |
$9K |
| 90716 |
|
1,424 |
1,379 |
$8K |
| 90715 |
|
437 |
427 |
$5K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
120 |
115 |
$5K |
| 99188 |
|
311 |
305 |
$5K |
| 90734 |
|
454 |
444 |
$4K |
| 99382 |
|
46 |
45 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
24 |
24 |
$4K |
| 90619 |
|
95 |
91 |
$3K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
27 |
25 |
$3K |
| 97802 |
|
117 |
114 |
$2K |
| 99384 |
|
14 |
13 |
$2K |
| 90685 |
|
31 |
26 |
$1K |
| 80061 |
Lipid panel |
569 |
560 |
$1K |
| 96127 |
|
725 |
700 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
13 |
13 |
$1K |
| 54150 |
|
14 |
12 |
$1K |
| 81025 |
|
196 |
187 |
$1K |
| 90681 |
|
160 |
159 |
$850.00 |
| 90698 |
|
26 |
26 |
$842.40 |
| 92587 |
|
66 |
65 |
$778.20 |
| 90697 |
|
167 |
161 |
$688.00 |
| 90620 |
|
118 |
111 |
$299.97 |
| 90674 |
|
14 |
14 |
$257.19 |
| 99174 |
|
902 |
790 |
$211.87 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
39 |
37 |
$192.24 |
| A7004 |
Small volume nonfiltered pneumatic nebulizer, disposable |
12 |
12 |
$15.12 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
12 |
12 |
$1.20 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
412 |
359 |
$0.00 |
| 90744 |
|
16 |
14 |
$0.00 |
| 90648 |
|
159 |
158 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
25 |
25 |
$0.00 |
| 96160 |
|
65 |
64 |
$0.00 |